Clinical Trials Logo

Brachial Plexus Block clinical trials

View clinical trials related to Brachial Plexus Block.

Filter by:
  • Enrolling by invitation  
  • Page 1

NCT ID: NCT03572686 Enrolling by invitation - Analgesia Clinical Trials

Dexamethasone at Lower Concentration Ropivacaine in the Supraclavicular Nerve Block

Start date: April 13, 2018
Phase: N/A
Study type: Interventional

The supraclavicular brachial plexus block is widely used in upper limb surgery below the shoulder. However, this can easily lead to long-term motor nerve blockage, Horner's syndrome, phrenic nerve paralysis or systemic poisoning, and even serious side effects such as cardiac arrest. Dexamethasone is a synthetic corticosteroid and becoming more common to use steroids as an adjunct to local anesthetics in brachial plexus block. In order to reduce the incidence of long-acting topical anesthetics from the nerve block in the supraclavicular arm, reducing the local anesthetic concentration is a feasible method, but this will also result in a shorter time to neurological block. The investigators hypothesized that the addition of Dexamethasone 5 mg to low concentrations (0.25%) of Ropivacaine would prolong postoperative analgesia.Therefore, the purpose of this study was to compare the postoperative analgesia and the side effects of postoperative supraclavicular brachial plexus blockade with the addition of Dexamethasone 5mg to Ropivacaine (0.5%) alone and Ropivacaine (0.25%) in low concentrations.